KVUE

Kenvue Inc.

19.15 USD
+0.01 (+0.05%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Kenvue Inc. stock is down -8.24% since 30 days ago. The next earnings date is Jun 20, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 1 February’s closed higher than January. In the last 10 Unusual Options Trades, there were 8 CALLs, 2 PUTs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
20 Feb 16:27 15 Mar, 2024 19.00 CALL 611 1590
20 Feb 18:39 17 Jan, 2025 20.00 CALL 204 4397
20 Feb 19:26 15 Mar, 2024 19.00 CALL 826 1590
20 Feb 20:07 08 Mar, 2024 19.50 CALL 5000 100
20 Feb 20:58 15 Mar, 2024 19.00 CALL 2256 1590
22 Feb 16:35 16 Aug, 2024 21.00 PUT 124 247
22 Feb 16:36 01 Mar, 2024 19.00 CALL 5000 5200
22 Feb 17:28 01 Mar, 2024 19.00 CALL 4600 5200
28 Feb 17:03 19 Apr, 2024 20.00 CALL 3574 2478
28 Feb 17:42 16 Jan, 2026 25.00 PUT 42 34

About Kenvue Inc.

We are the world’s largest pure-play consumer health company by revenue with $15.0 billion in net sales in 2022. We combine the power of science with meaningful human insights and digital-first capabilities, which we believe empowers approximately 1.2 billion people to live healthier lives every day. Prior to the completion of this offering, we are a wholly owned subsidiary of Johnson & Johnson. Our principal executive offices are located at 199 Grandview Road, Skillman, NJ.

  • RBC Capital
    Tue Feb 13, 10:29
    buy
    confirm
  • JP Morgan
    Fri Feb 9, 16:22
    buy
    confirm
  • RBC Capital
    Fri Feb 9, 11:17
    buy
    confirm